Evidence map›Paper›PMID 41645307›Full record

ReviewCell communication and signaling : CCS2026

Phase separation and the tumor microenvironment.

Wangwang Liu, Linhong Yu, Jianguo Xu, Yihan Yao, Tuomas P J Knowles, Yan-Li Zhang

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wangwang Liu *State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
Linhong Yu *State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
Jianguo Xu *State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
Yihan YaoYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
Tuomas P J KnowlesYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. tpjk2@cam.ac.uk.
Yan-Li ZhangState Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China. ylzhang@shsci.org.

Funding

National Natural Science Foundation of China 82273023
6 · The paper itself

Abstract

Liquid-Liquid Phase Separation (LLPS) is a physicochemical process which involves biomolecules spontaneously assembling into membrane-less biomolecular condensates through multivalent weak interactions. It emerges as a key factor regulating cellular homeostasis, and is widely involved in the spatiotemporal regulation of core cellular activities including gene expression and signal transduction. Notably, the dynamic process of LLPS is highly sensitive to extracellular microenvironmental cues, especially in the context of cancer. The Tumor Microenvironment (TME) is a dynamically heterogeneous environment characterized by metabolic dysregulation such as lactate accumulation and acidosis, hypoxia, nutrient deprivation, cytokine imbalance, and abnormal physicochemical signals. Accumulating evidence indicates that this specialized microenvironment exerts a profound regulatory effect on LLPS dynamics. This review systematically analyzes the bidirectional interaction between LLPS and TME, as well as the emerging opportunities to understand and influence tumor progression and emergence of therapeutic resistance by focusing on TME-LLPS crosstalk. We also highlight core challenges in this field, including the heterogeneity of LLPS and the associated dynamic processes, and the lack of tools for accurately monitoring condensate behavior in vivo. These opportunities and challenges motivate future research directions, focusing on the development of high-resolution LLPS imaging technologies, single-cell LLPS omics technologies, and therapeutic approaches targeting vulnerable sites of TME-LLPS such as YAP-TEAD condensate disruptors and pH-responsive modulators. Deciphering the LLPS-TME regulatory network is expected to provide support for redefining tumor heterogeneity and promoting the development of precision oncology.

Indexed as

NeoplasmsTumor MicroenvironmentAnimalsHumansPhase SeparationBiomolecular condensatesCancer therapy resistanceLiquid-Liquid phase separationTumor metabolismTumor microenvironment

Identifiers

PMID41645307
PMCPMC13224484

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.